AstraZeneca PLC (FRA:ZEG)

AstraZeneca Statistics

Total Valuation

AstraZeneca has a market cap or net worth of EUR 208.82 billion. The enterprise value is 230.81 billion.

Market Cap	208.82B
Enterprise Value	230.81B

Important Dates

The last earnings date was Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	Aug 7, 2025

Share Statistics

Current Share Class	1.55B
Shares Outstanding	n/a
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.13%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.54B

Valuation Ratios

The trailing PE ratio is 29.56 and the forward PE ratio is 16.05.

PE Ratio	29.56
Forward PE	16.05
PS Ratio	4.34
PB Ratio	5.47
P/TBV Ratio	n/a
P/FCF Ratio	21.94
P/OCF Ratio	18.32
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.99, with an EV/FCF ratio of 24.25.

EV / Earnings	32.68
EV / Sales	4.82
EV / EBITDA	13.99
EV / EBIT	18.99
EV / FCF	24.25

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.74.

Current Ratio	0.86
Quick Ratio	0.66
Debt / Equity	0.74
Debt / EBITDA	1.69
Debt / FCF	2.95
Interest Coverage	10.77

Financial Efficiency

Return on equity (ROE) is 19.67% and return on invested capital (ROIC) is 11.88%.

Return on Equity (ROE)	19.67%
Return on Assets (ROA)	8.28%
Return on Invested Capital (ROIC)	11.88%
Return on Capital Employed (ROCE)	18.19%
Revenue Per Employee	510,187
Profits Per Employee	74,901
Employee Count	94,300
Asset Turnover	0.52
Inventory Turnover	1.65

Taxes

In the past 12 months, AstraZeneca has paid 1.47 billion in taxes.

Income Tax	1.47B
Effective Tax Rate	17.17%

Stock Price Statistics

The stock price has decreased by -12.41% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-12.41%
50-Day Moving Average	124.43
200-Day Moving Average	128.62
Relative Strength Index (RSI)	66.91
Average Volume (20 Days)	12,179

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AstraZeneca had revenue of EUR 48.11 billion and earned 7.06 billion in profits. Earnings per share was 4.52.

Revenue	48.11B
Gross Profit	39.58B
Operating Income	12.22B
Pretax Income	8.53B
Net Income	7.06B
EBITDA	16.29B
EBIT	12.22B
Earnings Per Share (EPS)	4.52

Balance Sheet

The company has 6.05 billion in cash and 28.05 billion in debt, giving a net cash position of -22.00 billion.

Cash & Cash Equivalents	6.05B
Total Debt	28.05B
Net Cash	-22.00B
Net Cash Per Share	n/a
Equity (Book Value)	38.16B
Book Value Per Share	24.57
Working Capital	-3.91B

Cash Flow

In the last 12 months, operating cash flow was 11.40 billion and capital expenditures -1.88 billion, giving a free cash flow of 9.52 billion.

Operating Cash Flow	11.40B
Capital Expenditures	-1.88B
Free Cash Flow	9.52B
FCF Per Share	n/a

Margins

Gross margin is 82.26%, with operating and profit margins of 25.40% and 14.68%.

Gross Margin	82.26%
Operating Margin	25.40%
Pretax Margin	17.74%
Profit Margin	14.68%
EBITDA Margin	33.85%
EBIT Margin	25.40%
FCF Margin	19.78%

Dividends & Yields

This stock pays an annual dividend of 2.91, which amounts to a dividend yield of 2.21%.

Dividend Per Share	2.91
Dividend Yield	2.21%
Dividend Growth (YoY)	6.78%
Years of Dividend Growth	3
Payout Ratio	59.51%
Buyback Yield	-0.06%
Shareholder Yield	2.14%
Earnings Yield	3.38%
FCF Yield	4.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AstraZeneca has an Altman Z-Score of 2.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.98
Piotroski F-Score	6